In vitro diagnostic company that develops a rapid test for a faster sepsis diagnose through host immune system status.
Loop Dx has raised $803K in total funding. The most recent round was Seed. The last funding was announced in January 2023.
Loop Dx's investors include Capital Cell, Health Wildcatters.
Loop Dx is headquartered in Barcelona, Spain.
In vitro diagnostic company that develops a rapid test for a faster sepsis diagnose through host immune system status.
Loop Dx is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Loop Dx — Funding & Investors." VCBacked, January 1, 2023, https://www.vcbacked.co/company/loop-dx. Accessed July 19, 2026.
VCBacked. (2023). Loop Dx — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/loop-dx
{{cite web |title=Loop Dx — Funding & Investors |url=https://www.vcbacked.co/company/loop-dx |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated